Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Verifying results of efficacy for RCD405

Respiratorius reports positive preclinical milestone results from an ex vivo efficacy study of RCD405. The study has been conducted at a contract laboratory specialised in performing efficacy studies using human biospecimens, such as human lung tissue.In the study, RCD405 has been evaluated together with well-known bronchodilatory compounds in airway tissue from different species, i. e. rat, dog, and human. In all experiments a concentration-dependent dilatory effect of RCD405 was observed after induced constriction. In human airway tissue the relaxation was substantial and at least in the

BioStock Studio: Xintela expands to venous leg ulcers

Xintela has broadened the clinical development of its stem cell product XSTEM to include venous leg ulcers, the most common form of difficult-to-heal wounds in humans. Together with the Burn Centre at Linköping University Hospital, the company has shown that XSTEM provides good wound healing in a preclinical model. The next step for the company will be to apply for a clinical study in patients with venous leg ulcers, a study that Professor Folke Sjöberg from the Burn Centre tells us more about below.Watch the interview with Professor Folke Sjöberg at biostock.se: https://www.biostock.se/

TePe introduces TePe Supreme™ – a sustainable toothbrushing option

Following the introduction of TePe’s sustainable interdental brushes and speciality brushes, the TePe Supreme toothbrush is now relaunched as yet another step on TePe’s journey towards climate neutral product and packaging.“Climate action is one of our biggest concerns, and we know that renewable energy and materials have a significant impact on reducing emissions. At TePe, we are constantly working to broaden the offer of sustainable oral health products for consumers. Today, the main part of our range is made from sustainable sources and produced by 100% renewable energy”, says Helena

Martin Linde leaves the board of AcouSort for health reasons

Aegirbio announced yesterday that CEO Martin Linde is on sick leave. Martin Linde has also chosen to leave the board of AcouSort to focus on his recovery.The Board will shortly convene an Extraordinary General Meeting to elect a new Board member to replace Martin. The company would like to thank Martin for his great commitment and strong efforts over the years and wishes him a rapid recovery. For further information on AcouSort, please contact: Torsten Freltoft, CEOTelephone: +45 2045 0854E-mail: torsten.freltoft@acousort.com About AcouSort AcouSort AB (corporate

Invitation to presentation of Bulten’s Q3 report 2021

Bulten’s interim report for the period January – September 2021 will be published on Thursday 28 October 2021 at 13:30 CET.A presentation for analysts, media and investors will be held the same day at 15:30 CET during a webcasted teleconference. The report will be presented by President and CEO Anders Nyström and CFO Anna Åkerblad. The presentation will be held in English and include a Q&A session. Date: Thursday, October 28Time: The report will be published at 13:30 CET and the teleconference starts at 15:30 CET To participate in the teleconference, please dial in 5 minutes before

Metso Outotec to publish its Interim Report for January-September 2021 on Tuesday, November 2, 2021

Metso Outotec Corporation’s press release on October 12, 2021, at 09:30 a.m. EESTMetso Outotec’s Interim Report for January-September 2021 will be published on Tuesday, November 2, 2021 at about 9:00 a.m. EET and can be found on the Metso Outotec website .  Metso Outotec’s President and CEO Pekka Vauramo and CFO Eeva Sipilä will present the results in an audiocast and a conference call for analysts and investors on the same day at 13:00 p.m. EET.  The audiocast can be followedat the company’s website 

Modus Therapeutics - Symbiosis Pharmaceutical Services Starts Producing Sevuparin for Modus’ Future Clinical Development in Sepsis/septic shock

STOCKHOLM, SWEDEN – 12 October 2021: Modus Therapeutics Holding AB (“Modus”), a company developing innovative treatments for patients with high unmet medical needs, announces that Symbiosis Pharmaceutical Services Ltd (“Symbiosis”), a specialist contract manufacturing organization (CMO), has started manufacturing sevuparin drug product securing the supply for the Phase II clinical development in sepsis/septic shock and other conditions driven by systemic inflammation. This follows a recent drug supply agreement between Modus and Symbiosis covering the drug product needs for the Phase II

Inhalation Sciences and Karolinska Institutet renew partnership with new validation work and Mars dust study

(Stockholm, Sweden, 12 October 2021) In a renewed partnership Karolinska Institutet (KI) in Stockholm will help validate ISAB’s new XposeALI® MP (Micro Perfusion) tool, including using it to test a Mars dust surrogate for the European Space Agency as part of exploring future manned missions to Mars. XposeALI® MP is a highly automated new iteration of ISAB’s current cell culturing module and is expected to make in vitro lung studies simpler, more consistent and more cost-effective – including for biologics, a key priority area for inhaled drug developers.On Friday 8 October ISAB renewed its

Aarhus University Hospital, a Globally Leading Medical Institution, Begins Use of IRRAS’ IRRAflow System and Initiates Clinical Study to Validate its Efficacy

· Aarhus University Hospital in Denmark commenced its commercial use of the IRRAflow system for patients with intracranial bleeding · The hospital’s treatment experience with IRRAflow will be tracked and compared to treatment with traditional passive drainage as part of the ACTIVE clinical studyStockholm, October 12, 2021 - IRRAS, a global medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that Aarhus University Hospital in Aarhus, Denmark, one of the world's leading medical institutions, has initiated commercial use

Quickbit announces changes in Group management

Quickbit continues the strategy of broadening the company's target groups. The new phase, which began in the middle of the previous year, meant that the company broadened its offering to also include products aimed at the consumer market. Quickbit will develop easily accessible and secure financial services based on blockchain technology, aimed at both merchants and consumers. To better meet the challenges of the new phase and support the implementation, Quickbit is making changes in the Group management team.Simon Afeworki goes from a role as Head of Finance to a newly established role as

Akobo Minerals receives very positive results from its metallurgical testwork with potential for greater than previously expected revenue generation

Akobo Minerals has received the testwork results from the Peacocke and Simpson Laboratory. The positive results of these gold extraction tests give potential for greater than expected revenue generation to that proposed in the Scoping Study (27.09.2021), at similar operating costs.   The metallurgical testwork gives an indication of how much gold is expected to be recovered as if the cores/bulk samples had been treated with conventional gravity recovery and cyanide leaching unit operations. Samples were taken from a total of 3 holes drilled at Segele to generate  248kg for testwork

BioStock: RhoVac brings in Stifel as transaction advisor for RV001

Biotech company RhoVac has started the autumn by reaching several important milestones in its work with drug candidate RV001. Next year’s readout of  the phase IIb study BRaVac is rapidly approaching and the company is now contracting Investment Bank Stifel Nicolaus Europe as an advisor on the subsequent exit or partnership process. BioStock spoke to RhoVac’s CEO Anders Månsson to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/rhovac-brings-in-stifel-as-transaction-advisor-for-rv001/This is a press release from BioStock - Connecting Innovation &

Paulig and Lantmännen announce sustainable farming partnership

Today, the international food and beverage company Paulig announced a sustainable farming partnership with Lantmännen, a Swedish agricultural cooperative. As part of the collaboration, Swedish farmers will adopt even more sustainable cultivation methods within the framework of Lantmännen’s program for Farming of the Future: Climate & Nature. As of harvest 2022, Lantmännen Cerealia will supply Paulig with 17,000 tons of wheat flour cultivated in accordance with the program, reducing the climate impact by as much as 30 percent*. The flour will be used to annually produce 400 million Santa Maria

Read original

OKEA decides to halt further development of Vette discovery due to insufficient financial robustness

OKEA, as operator of the Vette licence (40% Working Interest (WI)), has decided to propose to the licence partners not to develop the Vette discovery further, due to the project’s insufficient financial robustness. OKEA took over operatorship of the licence earlier this year and has been maturing the discovery towards a DG2 decision.  OKEA has also worked to improve the economics of the Grevling/Storskrymten discoveries along with the license partners over the last few years. Although significant reductions in break-even cost have been achieved, it is deemed insufficient to warrant a

Elisa: Interim Report Q3 2021 publication on 20 October 2021

ELISA CORPORATION INVESTOR NEWS 12 OCTOBER 2021 AT 9:00 AMElisa will publish its Q3 2021 Interim Report from January–September on Wednesday 20 October 2021 at approximately 8:30 am EET (6:30 UK time). International conference call for analysts and investors will be held on the same day at 12:00 pm EET at Elisa headquarters, Ratavartijankatu 5, Helsinki. Dial-in numbers for the conference call, PIN: 59903102#FI: +358 9 8171 0310SE: +46 8 566 42651UK: +44 33 3300 0804US: +1 63 1913 1422 Live audiocast: https://elisa.videosync.fi/q3-2021 The presentations, and later

Paulig and Lantmännen announce sustainable farming partnership

Today, the international food and beverage company Paulig announced a sustainable farming partnership with Lantmännen, a northern European agricultural cooperative. As part of the collaboration, Swedish farmers will adopt even more sustainable cultivation methods within the framework of Lantmännen’s program for Farming of the Future: Climate & Nature. As of harvest 2022, Lantmännen Cerealia will supply Paulig with 17,000 tons of wheat flour cultivated in accordance with the program, reducing the climate impact by as much as 30 percent*. The flour will be used to annually produce 400 million

Metso Outotec expands battery chemicals filtration offering with modular DM1000 polishing filter

Metso Outotec Corporation’s press release on October 12, 2021, at 09:00 a.m. EESTMetso Outotec is introducing a new modular filter to its Dual Media (DM) filter product family. The compact Metso Outotec DM1000 polishing filter is particularly suitable for removing and recovering organic compounds and solids in small stream feeds in battery chemicals processes. Thanks to its modular design, the filter is easy to expand also for larger process flows. The DM1000 can be used as a traditional electrolyte filter in the extraction processes as well as for feed flow purification before

Invitation: Kemira to publish January-September 2021 results on October 26, 2021

Kemira Oyj, Press release, October 12, 2021 at 9.00 am (EEST)Invitation: Kemira to publish January-September 2021 results on October 26, 2021   Kemira Oyj will publish its January-September 2021 results on Tuesday, October 26, 2021 around 8.30 am Finnish time (6.30 am UK time).  Webcast for analysts, investors, and media will be held on Tuesday, October 26, 2021, starting at 10.30 am (8.30 am UK time). At the webcast, Kemira’s President and CEO Jari Rosendal and CFO Petri Castrén will present the results. The webcast will be held in English and can be followed at www.kemira.com/

Essity launches digital solution for wound management

Hygiene and health company Essity is launching Cutimed Wound Navigator, a new digital solution for wound assessment. To provide patients with the right and most suitable care, the innovative mobile app records key wound characteristics, generates an assessment and helps healthcare professionals to select the appropriate wound product.Essity has accelerated the digital transformation in all parts of its business. Cutimed Wound Navigator is an innovative digital[Cutimed Wound Navigator App] solution that supports in assessing and documenting wounds. The app records key wound characteristics

Resurs Holding presents interim report for the third quarter of 2021 – welcoming you to participate in person or digitally

Resurs is inviting investors and analysts to the presentation of the interim report for the third quarter on Tuesday, 26 October at 9:00 a.m. CEST. CEO Nils Carlsson and CFO & Head of IR Sofie Tarring Lindell will present the report and answer questions thereafter. You are welcome to participate in person in Stockholm or digitally.On Tuesday, 26 October at 7:30 a.m., Resurs Holding will publish its report for the third quarter of 2021. The report will be presented by CEO Nils Carlsson and CFO & Head of IR Sofie Tarring Lindell at 9:00 a.m. Join us at Helio GT 30, Grev Turegatan 30 in

Outokumpu’s third-quarter adjusted EBITDA higher than expected

Outokumpu OyjInside informationOctober 12, 2021 at 9.00 am EESTOutokumpu’s third-quarter adjusted EBITDA higher than expected Realized prices for stainless steel have increased more than expected and consequently Outokumpu’s adjusted EBITDA is expected to be higher compared to the second quarter. The company is in line with its volume guidance as stainless steel deliveries decreased by 8% compared to the second quarter. Outokumpu had earlier expected its third-quarter adjusted EBITDA to be at a similar level compared to the second quarter of 2021 (Q2/21: EUR 223 million).

Free Background Checks in Massachusetts for Looking Up Public Records: The Best MA Criminal and Arrest Records Search Engines Online

The state of Massachusetts requires a background check as part of the hiring process. Background checks are done by the MassachusettsDepartment of Criminal Justice  Information Services. Name-based or fingerprint-based background checks are available. Background checks may be used for employment, financing, personal, and residency in certain situations. Unofficial background checks can't be used for official business, but they may supply facts about your background: · Friends. · Relatives. · Co-Workers. · Romantic

Rye a better choice than wheat for weight loss

Eating whole grain rye products instead of refined wheat alternatives can offer worthwhile health benefits. Researchers at Chalmers University of Technology, Sweden, recently published a study showing that people who ate high-fibre products made from whole grain rye lost more body fat and overall weight than those who ate corresponding products made from refined wheat. The new results have been published in the scientific journal Clinical Nutrition. It is the largest study yet designed to evaluate the effects of particular types of grains on body weight and body fat, as well

Nomination Committee appointed for the Annual General Meeting 2022

The Nomination Committee ahead of the 2022 consists of: · Erik Malmberg, Actor SCA, Chair of the Nomination Committee · Mikael Holm-Lorsell, Alcur Fonder · Anette Dahlberg, Första AP-fonden · Lena Hofsberger, Chair of Ambea AB (publ).Shareholders who wish to submit proposals to the Nomination Committee can do so on the following e-mail address: valberedning@ambea.se or to below address: Ambea ABValberedningenc/o Johan Regnér Box 1565SE-171 29 Solna, Sweden The Nomination Committee’s proposals shall be presented in the convening notice made public before the

There are no items matching the current filter
There are no more items matching the current filter
Back to top